Naphthalene

Naphthalene

SCHEMBL303948

c1ccc2ccccc2c1.c1cocn1

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.40
ALOX12 P18054 1/20 0.40
CYP11B1 P15538 3/20 0.34
CYP11B2 P19099 3/20 0.34
CYP19A1 P11511 2/20 0.32
CYP17A1 P05093 1/20 0.32
PLAU P00749 2/20 0.32
NCF1 P14598 2/20 0.32
NOS2 P35228 2/20 0.32
BACE1 P56817 2/20 0.32
F12 P00748 1/20 0.32
NOS3 P29474 1/20 0.32
NOS1 P29475 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPK9 P45984 2/20 0.31
MAPK10 P53779 2/20 0.31
PLG P00747 1/20 0.31
MAPK8 P45983 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Naphthalene SCHEMBL9615518 1.00 CYP2A6 (0.40) CYP2A6ALOX12CYP11B1CYP11B2CYP19A1
Anthracene SCHEMBL26926677 0.91 ALDH1A1 (0.37) CYP2A6ALOX12CYP11B1CYP11B2CYP19A1
Oxazole SCHEMBL29213663 0.89
Isoquinoline SCHEMBL27772897 0.88 TNF (0.37) CYP11B1CYP11B2CYP19A1CYP17A1ALDH1A1
Phenanthrene SCHEMBL27708213 0.87 ALDH1A1 (0.50) CYP2A6PLAUNCF1NOS2BACE1
Triphenylene SCHEMBL21381928 0.85 LMNA (0.32) CYP2A6CYP11B1PLAUNCF1NOS2
Pyrene SCHEMBL3808718 0.84 ALDH1A1 (0.48) ALDH1A1
Oxazole SCHEMBL9215176 0.83 CYP2A6 (0.59) CYP2A6CYP11B1CYP11B2CYP19A1CYP17A1
Biphenyl SCHEMBL29228469 0.83 NOTUM (0.50) CYP2A6CYP19A1PLAUALDH1A1
Biphenyl SCHEMBL944174 0.83 NOTUM (0.50) CYP2A6CYP19A1PLAUALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 624 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702546-B2 Near-infrared heptamethine dyes for generation of singlet oxygen CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2023-07-18 US claimed
US-20230173071-A1 TREATMENT OF MYOPIA AND OTHER OCULAR CONDITIONS USING SINGLET OXYGEN GENERATED FROM DYES ACTIVATED BY NEAR-INFRARED LIGHT CALIFORNIA INST OF TECHN (US) 2023-06-08 US claimed
US-20200129620-A1 Treatment Of Myopia And Other Ocular Conditions Using Singlet Oxygen Generated From Dyes Activated By Near-Infrared Light CALIFORNIA INSTITUTE OF TECHNOLOGY 2020-04-30 US claimed
US-20200131370-A1 Near-Infrared Heptamethine Dyes For Generation Of Singlet Oxygen CALIFORNIA INSTITUTE OF TECHNOLOGY 2020-04-30 US claimed
CN-106715420-A crosslinkable host material 西诺拉股份有限公司 2017-05-24 CN claimed
CN-101460223-A Quinolones as Inducible Nitric Oxide Synthase Inhibitors KALYPSYS INC (US) 2009-06-17 CN claimed
EP-1609459-B1 Use of polycationic compounds for dyeing keratinous fibers OREAL (FR) 2009-04-08 EP claimed
JP-2008510698-A 2008-04-10 JP claimed
EP-1774047-A2 NUCLEIC ACID MELTING ANALYSIS WITH SATURATION DYES University of Utah Research Foundation (US) 2007-04-18 EP claimed
WO-2006121423-A2 NUCLEIC ACID MELTING ANALYSIS WITH SATURATION DYES UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2006-11-16 WO claimed
US-5410030-A Nucleic acid stains MOLECULAR PROBES, INC. (US) 1995-04-25 US claimed
EP-0568267-A2 Thermal transfer materials MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1993-11-03 EP claimed
US-5216166-A Cyanine dye with nitro group substituent MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1993-06-01 US claimed
EP-0465078-A1 Infra-red sensitive photographic materials MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1992-01-08 EP claimed
US-5030553-A Low minimum image density, storage stability FUJI PHOTO FILM CO., LTD. (JP) 1991-07-09 US claimed
EP-0399460-A2 Silver halide photograpic material FUJI PHOTO FILM CO., LTD. (JP) 1990-11-28 EP claimed
EP-0303301-A2 Silver halide photographic material FUJI PHOTO FILM CO., LTD. (JP) 1989-02-15 EP claimed
US-4463087-A Controlled site epitaxial sensitization of limited iodide silver halide emulsions EASTMAN KODAK COMPANY (US) 1984-07-31 US claimed
US-4435501-A SILVER HALIDE EMULSIONS EASTMAN KODAK COMPANY (US) 1984-03-06 US claimed
US-4425426-A SENSITIZING DYE ADSORBED TO SILVER HALIDE GRAINS EASTMAN KODAK COMPANY (US) 1984-01-10 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200129620-A1 Treatment Of Myopia And Other Ocular Conditions Using Singlet Oxygen Generated From Dyes Activated By Near-Infrared Light CRY1, MYH10, MYLK CYP2A6 2287/4885ALOX12 258/4885CYP11B1 982/4885
US-20230173071-A1 TREATMENT OF MYOPIA AND OTHER OCULAR CONDITIONS USING SINGLET OXYGEN GENERATED FROM DYES ACTIVATED BY NEAR-INFRARED LIGHT CRY1, MYH10, MYLK CYP2A6 2287/4885ALOX12 258/4885CYP11B1 982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.